skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.06d (Release date: 2017-06-26)
SearchBox Top
SearchBox Bottom
Bone Metastasis Targeting Peptide-11 (Code C82370)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: Bone Metastasis Targeting Peptide-11

Definition: A peptide that mimics naturally occurring interleukin-11 (IL-11) with interleukin receptor binding activity. Upon administration, bone metastasis targeting peptide-11 (BMTP-11) binds to interleukin-11 receptor alpha (IL-11Ra) BMTP-11. This agent might be used to deliver therapeutic agents specifically to IL-11Ra-expressing tumor cells while sparing normal cells. IL-11Ra is a cell surface receptor that may be overexpressed by osteosarcoma cells and by prostate cancer cells in prostate cancer bone metastases.

Display Name: Bone Metastasis Targeting Peptide-11

Label: Bone Metastasis Targeting Peptide-11

NCI Thesaurus Code: C82370 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: C2830059  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
Bone Metastasis Targeting Peptide-11

External Source Codes: 
PDQ Closed Trial Search ID 641166
PDQ Open Trial Search ID 641166 (check for NCI PDQ open clinical trial info)
UMLS CUI C2830059

Other Properties:
     Name Value (qualifiers indented underneath)
code C82370
Contributing_Source CTRP
Legacy_Concept_Name Bone_Metastasis_Targeting_Peptide-11
Semantic_Type Amino Acid, Peptide, or Protein
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom